Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.
Intuitive Surgical stock last closed at $399.09, down 0.25% from the previous day, and has increased 59.96% in one year. It has overperformed other stocks in the Medical Instruments & Supplies industry by 0.6 percentage points. Intuitive Surgical stock is currently +60.74% from its 52-week low of $248.29, and -1.16% from its 52-week high of $403.76.
As of Mar 28, 2024, there are 352.33M ISRG shares outstanding. The market cap of ISRG is $140.61B. In the last 24 hours, 1.1M ISRG shares were traded.
You will need an online brokerage account in order to access the NASDAQ market and buy ISRG shares.
Based on our experience, eToro is the best stock brokerage. Here's why:
Get $10 towards your purchase of shares by creating an account with eToro now.
Open eToro AccountNow that you've chosen the best brokerage, the next step is to fill out some personal information so you can invest in ISRG today.
Now that you have finished signing up on the best stock app for beginners, you need to deposit funds:
Check out the video below to see the process of depositing funds into your brokerage account.
After you have identified the best place to buy Intuitive Surgical stock, it's crucial to research their stock prior to investing, so you can comprehend the risk and opportunity.
WallStreetZen was designed to help average investors do better fundamental analysis quickly.
You can see all of the due diligence checks on ISRG's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge ISRG's intrinsic value.
Using relative valuations ratios:
You can do additional valuation analysis on ISRG's stock here.
Out of 14 sell side analysts who monitor ISRG, the consensus analyst rating on Intuitive Surgical is a Strong Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
Richard Newitter, a top 7% analyst from Truist Securities maintains ISRG with a strong buy rating and raises their ISRG price target from $390.00 to $435.00, on Jan 24, 2024.
Truist Securities's Richard Newitter raised their price target on Intuitive Surgical (NASDAQ: ISRG) by 11.5% from $390 to $435 on 2024/01/24. The analyst maintained their Strong Buy rating on the stock.
The company's next-gen da Vinci 5 is now at the FDA pending 510k approval, with its official launch window "now within sight," possibly as soon as this year, the analyst wrote in a note assessing Intuitive Surgical's Q4 and FY 2023 earnings beat, released on 2024/01/23.
Acknowledging that the combination of gross margin pressures, higher tax, and heavier operating expenses will likely weigh on FY 2024 EPS momentum, Newitter recommended that investors "look to FY 2025 and beyond."
"That is when revenue growth and re-expanding margins will drive healthy revenue and EPS growth back to the mid-teens range," the analyst predicted.
Intuitive reported:
For Q4 2023:
For FY 2023:
Management guided for FY 2024:
CEO Gary Guthart commented: “The past year was a good one for Intuitive with use of our platforms growing nicely, hospitals building additional system capacity to support that growth, and increased average utilization persistent per year for each of our platforms.
“Our teams have been delivering to meet customer demand, driving quality and availability improvements, running clinical trials, and readying new products and services for the market.”
Adam Maeder, a top 14% analyst from Piper Sandler maintains ISRG with a strong buy rating and raises their ISRG price target from $325.00 to $425.00, on Jan 24, 2024.
Larry Biegelsen, a top 12% analyst from Wells Fargo maintains ISRG with a strong buy rating and raises their ISRG price target from $363.00 to $416.00, on Jan 19, 2024.
Jason Bednar, a bottom 9% analyst from Raymond James maintains ISRG with a buy rating and raises their ISRG price target from $310.00 to $372.00, on Jan 3, 2024.
Cecilia Furlong, a bottom 12% analyst from Morgan Stanley maintains ISRG with a hold rating and raises their ISRG price target from $300.00 to $330.00, on Dec 4, 2023.
You can dive deeper into what analysts are forecasting on the Intuitive Surgical stock forecast page.
Last year, ISRG earnings were $1.80B. During the last 5 year, ISRG's earnings have gone up by 9.14% per year. This was slower than the Medical Instruments & Supplies industry average of 16.14%.
Last year, ISRG revenue was $7.12B. In the past five year, ISRG's revenue has grown by 13.85% per year. This was faster than the Medical Instruments & Supplies industry average of 9.57%.
Find out more about ISRG's earnings and revenue performance here.
In the past year, insiders at ISRG have bought more shares than they have sold.
Fredrik Widman, VP Corporate Controller of ISRG, was the latest ISRG insider to sell. They sold $243,006.84 worth of ISRG stock on Mar 15, 2024.
Learn more about who owns ISRG shares here.
No, Intuitive Surgical doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
There are two main order types:
Press the Open button and eToro will place your order.
If you require more assistance investing in stocks on eToro, watch the how to video below:
Now that you own some ISRG stock, you'll want to stay up-to-date on your investment.
Add ISRG to a watchlist to get notified of the latest news about your ISRG stock.
To reiterate, here are the 6 steps you need to take to buy Intuitive Surgical stock right now:
If you require a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get the latest scoop on your new investment in Intuitive Surgical, hit the button below to create your watchlist.